1615PDA phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults: Epithelioid sarcoma cohort (NCT02601950). (23rd October 2018) - Gounder, M; Schöffski, P; Villalobos, V; Cote, G; Chugh, R; Chen, T W-W; Jahan, T; Loggers, E T; Italiano, A; Gupta, A; Agulnik, M; Attia, S; et al.